Traditional branding competes to be better in an existing market. Category design is a business discipline that changes how the market defines a problem, creating a new space in customers' minds where your company is the only choice. This makes you irreplaceable, not just an incremental improvement.
To build an enduring company, ask this critical question: 'If we disappeared tomorrow, what problem would remain unsolved, and would anyone notice?' The goal is to become so essential in solving an urgent problem that your customers would revolt if your solution was no longer available.
Many MedTech companies mistakenly believe a clinically superior product will automatically win market share. This is false. Market adoption is not automatic; it must be designed as intentionally as the product itself to overcome the powerful inertia of the status quo and make the market mentally ready for change.
When fundraising, pitch the creation of a new market category, not just a better product. Investors view incremental improvements as capped opportunities fighting for existing market share. They disproportionately fund 'different' companies that can create, own, and dominate an entirely new market space.
Shockwave Medical exemplifies category design. Instead of competing with existing tools, they reframed severe arterial calcium as a distinct disease state requiring treatment before the primary procedure. This shift made existing tools seem inadequate and positioned their technology as the only logical solution.
Companies focus on internal checklists like regulatory approval and sales readiness, assuming the market is prepared for their innovation. This is a critical error. The external market is still anchored in the old way of thinking, creating a belief gap that a larger sales team or better messaging cannot fix post-launch.
MedTech's data-driven culture fosters a false belief that strong clinical data is sufficient to drive adoption. In reality, all humans—including surgeons—make decisions emotionally first. Data's primary role is not to create initial belief but to provide rational validation for a change the market has already been primed to make.
While you cannot promote a MedTech product before regulatory approval, you can and should promote the problem it solves. This 'problem marketing' strategy rewires the audience's thinking, making them feel the pain of the status quo. By the time your product launches, the market is already primed to seek your solution.